X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (135) 135
Publication (26) 26
Book / eBook (13) 13
Book Chapter (2) 2
Dissertation (2) 2
Newspaper Article (2) 2
Conference Proceeding (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (60) 60
index medicus (57) 57
female (50) 50
oncology (49) 49
adult (26) 26
middle aged (26) 26
aged (25) 25
male (25) 25
cancer (20) 20
breast cancer (18) 18
breast neoplasms - drug therapy (17) 17
medicine & public health (16) 16
tumors (16) 16
neoplasms - drug therapy (15) 15
animals (14) 14
article (14) 14
research (14) 14
solid tumors (14) 14
treatment outcome (14) 14
aged, 80 and over (13) 13
medical and health sciences (12) 12
medicin och hälsovetenskap (12) 12
abridged index medicus (11) 11
therapy (11) 11
antineoplastic combined chemotherapy protocols - therapeutic use (10) 10
care and treatment (10) 10
maximum tolerated dose (10) 10
patients (10) 10
antineoplastic agents - therapeutic use (9) 9
antineoplastic combined chemotherapy protocols - adverse effects (9) 9
breast neoplasms - metabolism (9) 9
paclitaxel (9) 9
studies (9) 9
surgery (9) 9
chemotherapy (8) 8
clinical trials (8) 8
drug administration schedule (8) 8
paclitaxel - administration & dosage (8) 8
pharmacokinetics (8) 8
pharmacology & pharmacy (8) 8
pharmacology/toxicology (8) 8
apoptosis (7) 7
breast neoplasms - pathology (7) 7
clinical trials as topic (7) 7
health aspects (7) 7
metastases (7) 7
metastasis (7) 7
mutation (7) 7
neoplasm metastasis (7) 7
risk factors (7) 7
safety (7) 7
area under curve (6) 6
autolysosome (6) 6
autophagosome (6) 6
blood pressure (6) 6
breast neoplasms - genetics (6) 6
cancer research (6) 6
cell lung-cancer (6) 6
children (6) 6
dose-response relationship, drug (6) 6
flux (6) 6
lc3 (6) 6
lysosome (6) 6
medicine (6) 6
neoplasms - pathology (6) 6
phagophore (6) 6
stress (6) 6
toxicity (6) 6
vacuole (6) 6
antibodies, monoclonal - adverse effects (5) 5
antineoplastic agents - adverse effects (5) 5
autism (5) 5
cancer therapies (5) 5
carboplatin (5) 5
cell biology (5) 5
child (5) 5
child, preschool (5) 5
complications and side effects (5) 5
disease (5) 5
expression (5) 5
genetic aspects (5) 5
hypertension (5) 5
intravenous administration (5) 5
mice (5) 5
neoplasm staging (5) 5
original (5) 5
original article (5) 5
pharmacology (5) 5
phase-i (5) 5
phase-ii (5) 5
trial (5) 5
tyrosine kinase inhibitor (5) 5
1840-1917 (4) 4
1st-line therapy (4) 4
administration, oral (4) 4
adolescent (4) 4
antibodies, monoclonal - administration & dosage (4) 4
antibodies, monoclonal - therapeutic use (4) 4
antibodies, monoclonal, humanized (4) 4
antimitotic agents (4) 4
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Robarts - Stacks (7) 7
Collection Dvlpm't (Acquisitions) - Vendor file (4) 4
Art - Library use only (2) 2
UofT at Scarborough - Stacks (2) 2
Collection Dvlpm't (Acquisitions) - Closed Orders (1) 1
Gerstein Science - Stacks (1) 1
Online Resources - Online (1) 1
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (1) 1
UTL at Downsview - May be requested (1) 1
UofT at Mississauga - Oversize (1) 1
UofT at Mississauga - Stacks (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


2010, Emerging cancer therapeutics, ISBN 1936287145, Volume 1, issue 3
Book
01/2018, ISBN 9783319699790, 187
This guide provides practical information that will assist clinicians involved in the diagnosis, assessment, treatment, and follow-up care of patients with... 
Breast-Cancer
eBook
2018, ISBN 3319699806
This guide provides practical information that will assist clinicians involved in the diagnosis, assessment, treatment, and follow-up care of patients with... 
Medicine | Gynecology | Radiology | Oncology | Surgical oncology
Web Resource
Journal of Clinical Oncology, ISSN 0732-183X, 05/2019, Volume 37, Issue 15_suppl, pp. 3132 - 3132
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 03/2017, Volume 35, Issue 7_suppl, pp. 44 - 44
44 Background: Lack of test standardization and conflicting results on PD1 and PD-L1 immunohistochemistry (IHC) assays challenge their use as predictive... 
Journal Article
Clinical Advances in Hematology and Oncology, ISSN 1543-0790, 07/2018, Volume 16, Issue 7, pp. 491 - 501
The poly(ADP-ribose) polymerases (PARPs) 1 and 2 are DNA-binding enzymes that play a critical role in the repair of DNA. The use of PARP inhibitors is a... 
Triple-negative | Breast cancer | BRCA1 | BRCA2 | PARP inhibitors
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 05/2017, Volume 35, Issue 15_suppl, pp. 11581 - 11581
Journal Article
Seminars in Oncology, ISSN 0093-7754, 06/2016, Volume 43, Issue 3, pp. 331 - 334
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 05/2014, Volume 32, Issue 15_suppl, pp. 2595 - 2595
Journal Article
Glia, ISSN 0894-1491, 09/2013, Volume 61, Issue 9, pp. 1556 - 1569
  Autistic individuals display impaired social interactions and language, and restricted, stereotyped behaviors. Elevated levels of secreted amyloid precursor... 
Proteins | Autism | Behavior | Rodents | Alzheimer's disease
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 05/2015, Volume 33, Issue 15_suppl, pp. 11086 - 11086
Journal Article
PLoS ONE, ISSN 1932-6203, 03/2014, Volume 9, Issue 3, p. e90353
Background: In advanced cancers, transforming growth factor-beta (TGFb) promotes tumor growth and metastases and suppresses host antitumor immunity. GC1008 is... 
SURVIVAL | EPITHELIAL-MESENCHYMAL TRANSDIFFERENTIATION | INHIBITION | SOLID TUMORS | EFFICACY | VIVO | MULTIDISCIPLINARY SCIENCES | METASTATIC BREAST-CANCER | KERATOACANTHOMAS | T-CELLS | PROGRESSION | Humans | Middle Aged | Antibodies, Monoclonal - therapeutic use | Male | Tomography, X-Ray Computed | Antineoplastic Agents - therapeutic use | Positron-Emission Tomography | Kidney Neoplasms - diagnosis | Aged, 80 and over | Transforming Growth Factor beta - antagonists & inhibitors | Adult | Female | Antineoplastic Agents - pharmacology | Carcinoma, Renal Cell - drug therapy | Carcinoma, Renal Cell - pathology | Antibodies, Monoclonal - pharmacology | Treatment Outcome | Melanoma - pathology | Transforming Growth Factor beta - blood | Carcinoma, Renal Cell - diagnosis | Melanoma - drug therapy | Kidney Neoplasms - pathology | Aged | Kidney Neoplasms - drug therapy | Neoplasm Staging | Oncology, Experimental | Melanoma | Clinical trials | Monoclonal antibodies | Bone morphogenetic proteins | Research | Carcinoma, Renal cell | Metastasis | Transforming growth factors | Cancer | Intravenous administration | Toxicity | Transforming growth factor-b | Medical treatment | Transforming growth factor-a | Pharmacology | Patients | Immunity | Constraining | Metastases | Anticancer properties | Isoforms | Biomarkers | Antitumor activity | Safety | Clear cell-type renal cell carcinoma
Journal Article
The Lancet Oncology, ISSN 1470-2045, 10/2017, Volume 18, Issue 10, pp. 1360 - 1372
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.